Testing BAY 43-9006

Testing BAY 43-9006

Study (status) Indication Primary endpoint Secondary endpoint
Ph III (ongoing) RCC Overall survival Response rate (RR) Time to progression (TTP)
Design: More than 800

Read the full 285 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE